Nutritional assessment of infants with cystic fibrosis diagnosed through screening
- PMID: 1782132
- DOI: 10.1002/ppul.1950110712
Nutritional assessment of infants with cystic fibrosis diagnosed through screening
Abstract
Presymptomatic infants diagnosed through neonatal screening for cystic fibrosis can have biochemical evidence of malnutrition. With aggressive dietary management and treatment with pancreatic enzymes, normal biochemical indices of nutrition can be achieved at 12 months of life in most cases. Males with cystic fibrosis appear to be more at risk than females for abnormal growth and biochemical indices of nutrition in the first year of life. This may be related to the observed decrease in fat intake when compared to females. Males, especially, should be carefully observed for development of nutritional abnormalities based on this data. Careful attention should be paid to vitamin E and essential fatty acid status in all CF infants. The numbers in this study are small and the long-term consequences of early nutritional intervention await the conclusion of the randomized, controlled study on-going in Wisconsin.
Similar articles
-
An overview of international literature from cystic fibrosis registries 2. Neonatal screening and nutrition/growth.J Cyst Fibros. 2010 Mar;9(2):75-83. doi: 10.1016/j.jcf.2009.11.002. Epub 2009 Dec 2. J Cyst Fibros. 2010. PMID: 19955022 Review.
-
Nutritional challenges of infants with cystic fibrosis.Early Hum Dev. 2001 Nov;65 Suppl:S53-61. doi: 10.1016/s0378-3782(01)00206-7. Early Hum Dev. 2001. PMID: 11755035 Review.
-
Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.Pediatrics. 2001 Jan;107(1):1-13. doi: 10.1542/peds.107.1.1. Pediatrics. 2001. PMID: 11134427 Clinical Trial.
-
Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening.Pediatrics. 2000 Jan;105(1 Pt 1):53-61. doi: 10.1542/peds.105.1.53. Pediatrics. 2000. PMID: 10617704
-
Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.N Engl J Med. 1997 Oct 2;337(14):963-9. doi: 10.1056/NEJM199710023371403. N Engl J Med. 1997. PMID: 9395429 Clinical Trial.
Cited by
-
Antioxidant supplementation for lung disease in cystic fibrosis.Cochrane Database Syst Rev. 2019 Oct 3;10(10):CD007020. doi: 10.1002/14651858.CD007020.pub4. Cochrane Database Syst Rev. 2019. PMID: 31580490 Free PMC article. Review.
-
Newborn screening for cystic fibrosis.Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD001402. doi: 10.1002/14651858.CD001402.pub2. Cochrane Database Syst Rev. 2009. PMID: 19160197 Free PMC article. Review.
-
Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003.Free Radic Biol Med. 2007 Jan 1;42(1):15-31. doi: 10.1016/j.freeradbiomed.2006.09.022. Epub 2006 Sep 29. Free Radic Biol Med. 2007. PMID: 17157190 Free PMC article.
-
Normal growth in cystic fibrosis associated with a specialised centre.Arch Dis Child. 1999 Sep;81(3):241-6. doi: 10.1136/adc.81.3.241. Arch Dis Child. 1999. PMID: 10451398 Free PMC article.